SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- diabetes
An SI Board Since June 2001
Posts SubjectMarks Bans
278 35 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
228Indeed, I haven't anything from that Kos program in YEARS. I think there matuck-3/8/2008
227ABT nominally still has a program acquired from Kos, although I doubt it will seDewDiligence_on_SI-3/7/2008
226MannKind may soon be alone in the inhaled insulin arena, as Alkermes and Lilly btuck-3/7/2008
225Roger that. Still working on first cup of Green Mt :-)DewDiligence_on_SI-1/25/2008
224Thanks for the pointer, but I said "not new news." :) rkrw-1/25/2008
223<i>…interesting that one of the worlds biggest diabetes company's is dDewDiligence_on_SI-1/25/2008
222Not new news, but still interesting that one of the worlds biggest diabetes comprkrw-1/25/2008
221<b>Protein power: Researchers trigger insulin production in diabetic mice&idos-1/10/2008
220[PPAR-gamma regulates osteoclastogenesis in mice: glitazones cause osteoporosis tuck-12/6/2007
219<b>Antibody Therapy Shows Promise for Diabetes</B> By Jennifer Couzidos-12/4/2007
218New mechanism of insulin release discovered [PRESS RELEASE 23 November 2007] A Icebrg-11/23/2007
217Lilly and MacroGenics Announce Licensing and Collaboration Agreement Thursday Ocnigel bates-10/18/2007
216Liraglutide is looking even better... <b>FDA Warns of Pancreatitis Risk AIan@SI-10/16/2007
215Non-insulin therapies for type 2 diabetes Mona Ashiya1 & Richard E. T. Smitdr.praveen-10/1/2007
214Geez Tuck, I asked for a small cap. You just sent me from $40B NVO to $190B JNJIan@SI-9/28/2007
213>>Liraglutide. Anyone know if L is wholly owned by Novo Nordisk? ... or ituck-9/28/2007
212Here's one PhIII trial participant's reaction to Liraglutide. Anyone knIan@SI-9/28/2007
211Endocrine Regulation of Energy Metabolism by the Skeleton Na Kyung Lee,1 Hideaktnsaf-8/11/2007
210Rheoscience and Dr. Reddy's Commence the First Phase III Trial of Balaglitaznigel bates-8/1/2007
209Message 23731305scaram(o)uche-7/25/2007
208Older, Cheaper Diabetes Drugs As Good As New Ones - Study THE ASSOCIATED PREIan@SI-7/16/2007
207Takeda Drops Actos/TAK-536 Combo Drug: investorshub.comDewDiligence_on_SI-6/1/2007
206ummm... good luck with your investment.kenhott-5/7/2007
205Clinical Beta cell function and metabolic control during two years of follow-up B O Trust-5/7/2007
204They like to use words like "startling" and "revolutionary" kenhott-5/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News